The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjects
about
Single-dose safety and pharmacokinetics of brecanavir, a novel human immunodeficiency virus protease inhibitorPharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant womenLopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosisTherapeutic drug monitoring of lopinavir/ritonavir in pregnancy.
P2860
The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjects
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
The unbound percentage of saqu ...... erval in HIV positive subjects
@ast
The unbound percentage of saqu ...... erval in HIV positive subjects
@en
type
label
The unbound percentage of saqu ...... erval in HIV positive subjects
@ast
The unbound percentage of saqu ...... erval in HIV positive subjects
@en
prefLabel
The unbound percentage of saqu ...... erval in HIV positive subjects
@ast
The unbound percentage of saqu ...... erval in HIV positive subjects
@en
P2093
P2860
P1476
The unbound percentage of saqu ...... erval in HIV positive subjects
@en
P2093
Alessandro Sinicco
David J Back
E Rhiannon Meaden
Giovanni Di Perri
Helen E Reynolds
Marta Boffito
Patrick G Hoggard
Stefano Bonora
P2860
P304
P356
10.1046/J.1365-2125.2002.01663.X
P407
P577
2002-09-01T00:00:00Z